Life ScienceCompany
Viatris - Biosimilars Ownership
Who owns Viatris - Biosimilars?
Viatris - Biosimilars is owned by Biocon. It was acquired on February 28, 2022.
Viatris - Biosimilars Business Overview
Where is Viatris - Biosimilars headquartered?
Viatris - Biosimilars is headquartered in Canonsburg, Pennsylvania.
What sector is Viatris - Biosimilars in?
Viatris - Biosimilars is a life science company.
Life Science M&A Summary in 2022
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2022. The largest life science acquisition in 2022 was Horizon Therapeutics Public Limited Company - which was acquired by Amgen for $27.8B.
Join Mergr to view all 296 acquisitions of life science companies in 2022, including 37 acquisitions by private equity firms, and 259 by strategics.